본문 바로가기
KERD
논문KCI 등재

동반된 양성 갑상선 질환에 따른 갑상선 유두암의 임상병리학적 특성

Clinical Characteristics of Papillary Carcinomas with Other Benign Pathologies

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Purpose: Thyroid papillary carcinoma is the most common endocrine tumor. There are many known factors affecting the pathophysiology of papillary carcinomas. In this study, we attempted to determine the clinical characteristics of papillary carcinomas with other benign pathologies. Methods: From May 2007 to December 2012, a total of 994 patients underwent thy-roidectomy and were diagnosed as papillary carcinomas. Retrospective study was per-formed using medical records. We categorized them according to five groups depending on associated benign disease, Papillary carcinoma with Graves disease (Group 1), Multinodular goiter (Group 2), Hashimoto thyroiditis (Group 3), Multinodular goiter and Hashimoto thyroiditis (Group 4), and Papillary carcinoma only (Group 5), and we performed a comparison analysis. Results: T and N stage of group 2 were lower than those of group 5 and T stage of group 3 was lower than that of group 4. T and N stage of group 4 were lower than those of group 5 and extrathyroidal extension rate of group 4 was lower than that of group 5. Conclusion: Papillary carcinomas have variable clinical characteristics according to underlying benign thyroid disease. Conduct of advanced research regarding the mecha-nisms of the effect of benign thyroid disease on papillary carcinomas is needed.

Abstract

Purpose: Thyroid papillary carcinoma is the most common endocrine tumor. There are many known factors affecting the pathophysiology of papillary carcinomas. In this study, we attempted to determine the clinical characteristics of papillary carcinomas with other benign pathologies. Methods: From May 2007 to December 2012, a total of 994 patients underwent thy-roidectomy and were diagnosed as papillary carcinomas. Retrospective study was per-formed using medical records. We categorized them according to five groups depending on associated benign disease, Papillary carcinoma with Graves disease (Group 1), Multinodular goiter (Group 2), Hashimoto thyroiditis (Group 3), Multinodular goiter and Hashimoto thyroiditis (Group 4), and Papillary carcinoma only (Group 5), and we performed a comparison analysis. Results: T and N stage of group 2 were lower than those of group 5 and T stage of group 3 was lower than that of group 4. T and N stage of group 4 were lower than those of group 5 and extrathyroidal extension rate of group 4 was lower than that of group 5. Conclusion: Papillary carcinomas have variable clinical characteristics according to underlying benign thyroid disease. Conduct of advanced research regarding the mecha-nisms of the effect of benign thyroid disease on papillary carcinomas is needed.

참고문헌 (16)

  1. "Cancer", 1998, 2638~2648
  2. Nikiforov YE, "Risk factors for thyroid cancer", Trends Endocrinol Metab, 8, pp.20~25 (1997)
  3. Eden K, "Screening high-risk populations for thyroid cancer", Med Pediatr Oncol, 36, pp.583~591 (2001)
  4. Eng C, "Familial papillary thyroid cancer--many syndromes, too many genes?", J Clin Endocrinol Metab, 85, pp.1755~1757 (2000)
  5. Zhang Y, "The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma", J Cancer Res Clin Oncol, 140, pp.1021~1026 (2014)
  6. Pelizzo MR, "Cancer in multinodular goiter", Ann Ital Chir, 67, pp.351~356 (1996)
  7. Sachmechi I, "Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters", Endocr Pract, 6, pp.5~7 (2000)
  8. Cole WH, "Incidence of carcinoma of the thyroid in nodular goiter", Semin Surg Oncol, 7, pp.61~63 (1991)
  9. Mattioli FP, "Surgical treatment of multinodular goiter", Ann Ital Chir, 67, pp.341~345 (1996)
  10. 이관주, "갑상선 미세 유두암에서 종양 크기의 구분에 따른 임상병리학적 특징의 분석", 대한내분비외과학회지, 10(3), pp.152~156 (2010), 대한갑상선-내분비외과학회
  11. Ito Y, "An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid", Thyroid, 13, pp.381~387 (2003)
  12. Roti E, "Thyroid papillary microcarcinoma: a descriptive and meta-analysis study", Eur J Endocrinol, 159, pp.659~673 (2008)
  13. Ito Y, "An observational trial for papillary thyroid microcarcinoma in Japanese patients", World J Surg, 34, pp.28~35 (2010)
  14. Fiore E, "L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer:results of a cross-sectional study on 27 914 patients", Endocr Relat Cancer, 17, pp.231~239 (2010)
  15. Fiore E, "Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease", J Clin Endocrinol Metab, 97, pp.1134~1145 (2012)
  16. Pascual Corrales E, "Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter", Endocrinol Nutr, 59, pp.169~173 (2012)

관련 논문AI추천

하시모토 갑상선염 유무에 따른 갑상선 유두암의 임상병리학적 분석강동현, 김성용, 우희두, 한선욱, 허성모대한내분비외과학회 · Journal of Endocrine Surgery2013 · 제13권 제4호하시모토 갑상선염을 동반한 유두상 갑상선암의 임상병리학적 특징강상현, 김광희, 김기훈, 김상효, 김운원, 김진수, 김태현, 박하경, 배기범, 신재호, 안민성, 이홍태, 최창수, 하태권대한내분비외과학회 · Journal of Endocrine Surgery2013 · 제13권 제1호하시모토 갑상선염이 유두상 갑상선암의 예후 인자인가?윤현조, 이민주, 이병길, 정성후대한내분비외과학회 · Journal of Endocrine Surgery2010 · 제10권 제1호수술 전 혈청 갑상선 자극 호르몬(TSH)수치와 갑상선 유두암과의 상관관계김성용, 김재우, 김창호, 박래경, 백무준, 송금종, 우희두, 이진형, 한선욱대한내분비외과학회 · Journal of Endocrine Surgery2012 · 제12권 제3호하시모토 갑상선염을 동반한 갑상선유두암에서 BRAFV600E 돌연변이의 임상병리학적 의미권혜미, 김미진, 김원구, 김원배, 김태용, 박수연, 송영기, 전민지, 최윤미대한갑상선학회 · International Journal of Thyroidology2016 · 제9권 제1호유두상 갑상선암에서 최소 갑상선외 침범의 예후인자로서의 유용성김광희, 김상효, 김태현, 박하경, 배기범, 신재호, 안민성, 이민재, 이홍태, 최창수, 하태권대한내분비외과학회 · Journal of Endocrine Surgery2012 · 제12권 제2호

이 간행물의 다른 논문 (3건)